Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
In vivo
EIP Pharma Announces Presentation of Preclinical Data Demonstrating Effects of p38?…
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Newer Targets
Marathon-running molecule could speed up the race for new neurological treatments
Newer Targets
Targeting a key protein may keep ovarian cancer cells from spreading
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Recall
Phase II
Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for…
Approval
Blueprint Medicines Announces European Medicines Agency Validation of Marketing Authorization Application…
Phase I
Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial…
Phase II
InflaRx Reports Additional Analysis of the SHINE Phase IIb Results for…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Deals
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi…
Deals
Mallinckrodt To Make An Equity Investment In Silence Therapeutics As Part…
Commercial
Novartis Close to Settling Kickback Lawsuit
Deals
Predictive Oncology Subsidiary Helomics Collaborates with UPMC to Establish a Data…
Home
Therapy areas
Therapy areas
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Others
36 Certified Great Places to Work By BioSpace Hotbed Regions
Biospace News
-
July 18, 2019
Others
BioSpace Global Roundup, July 18
Others
Certified Great Places to Work By BioSpace Hotbed Regions
Others
Genmab Raises $506 Million in IPO
Others
Hansa Biopharma Interim Report January-June 2019
Others
Takeda Eyes Additional Divestitures to Pare Down Shire Deal Debt
Biospace News
-
July 18, 2019
0
Others
Proposed gene therapy for a heart arrhythmia, based on models made...
Firstwordpharma News
-
July 18, 2019
0
Others
China Has Big Presence in Top 10 Biotech IPOs this Year
Biospace News
-
July 17, 2019
0
Others
RI Bio Interview: Rhode Island Sets the Stage for Long-Term Life...
Biospace News
-
July 17, 2019
0
Others
Release of Federal Database Reveals 76 Billion Opioid Pills Were Sold...
Biospace News
-
July 17, 2019
0
1
2
3
...
194
Page 1 of 194
- Advertisement -
MOST POPULAR
Novartis to Acquire IFM Tre to Develop First-In-Class NLRP3 Antagonist Portfolio...
April 1, 2019
Eli Lilly’s Lartruvo Failure Puts a Crimp in Its Plans for...
February 6, 2019
Allergan Announces FDA Acceptance of New Drug Application for Ubrogepant for...
March 11, 2019
Alnylam Submits Marketing Authorization Application to the European Medicines Agency for...
July 1, 2019
Load more
HOT NEWS
Acquisitions
SIFI announces expansion on the French market with the acquisition of...
Others
Insmed Announces Proposed Public Offering of Common Stock – May 20,...
Commercial
Realm Therapeutics Announces Cancellation of AIM Listing
Commercial
Alpine Immune Sciences to Present at Upcoming Investor Conferences
